Tonui WK - Search Results

1

Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis.

Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK. Tonui WK, et al. East Afr Med J. 2001 Feb;78(2):84-9. doi: 10.4314/eamj.v78i2.9094. East Afr Med J. 2001. PMID: 11682952

2

Experimental immunization against cutaneous leishmaniasis using Leishmania major subcellular fractions alone or in combination with Phlebotomus duboscqi gut antigens.

Mbati PA, Anjili CO, Lugalia R, Mwanyumba P, Tonui WK, Robert LL, Githure JI. Mbati PA, et al. Among authors: tonui wk. East Afr Med J. 1995 Aug;72(8):519-22. East Afr Med J. 1995. PMID: 7588148

3

Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.

Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK. Tonui WK, et al. East Afr Med J. 2001 Feb;78(2):90-2. East Afr Med J. 2001. PMID: 11682953

4

Leishmania donovani-derived lipophosphoglycan plus BCG induces a Th1 type immune response but does not protect Syrian golden hamsters (Mesocricetus auratus) and BALB/c mice against Leishmania donovani.

Tonui WK, Mpoke SS, Orago AS, Turco SJ, Mbati PA, Mkoji GM. Tonui WK, et al. Onderstepoort J Vet Res. 2003 Dec;70(4):255-63. doi: 10.4102/ojvr.v70i4.290. Onderstepoort J Vet Res. 2003. PMID: 14971728

5

Leishmania major-Phlebotomus duboscqi interactions: inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopes.

Tonui WK, Ngumbi PM, Mpoke SS, Orago AS, Mbati PA, Turco SJ, Mkoji GM. Tonui WK, et al. East Afr Med J. 2004 Feb;81(2):97-103. doi: 10.4314/eamj.v81i2.9133. East Afr Med J. 2004. PMID: 15125094

6

Vaccinations with live-attenuated Leishmania major promastigotes and challenge infection with L. major in BALB/c mice.

Onyalo JA, Mwala DM, Anjili CO, Orago AS, Tonui WK. Onyalo JA, et al. Among authors: tonui wk. East Afr Med J. 2005 Apr;82(4):193-7. East Afr Med J. 2005. PMID: 16122087

7

Estimation of the minimum number of Leishmania major amastigotes required for infecting Phlebotomus duboscqi (Diptera: Psychodidae).

Anjili C, Langat B, Lugalia R, Mwanyumba P, Ngumbi P, Mbati PA, Githure J, Tonui WK. Anjili C, et al. Among authors: tonui wk. East Afr Med J. 2006 Feb;83(2):68-71. East Afr Med J. 2006. PMID: 16708876

8

Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).

Anjili C, Langat B, Ngumbi P, Mbati PA, Githure J, Tonui WK. Anjili C, et al. Among authors: tonui wk. East Afr Med J. 2006 Feb;83(2):72-8. East Afr Med J. 2006. PMID: 16708877

9

Leishmania transmission-blocking vaccines: a review.

Tonui WK. Tonui WK. East Afr Med J. 1999 Feb;76(2):93-6. East Afr Med J. 1999. PMID: 10442130 Review.

10

Leishmania major infections in Phlebotomus duboscqi fed on murine models immunized with L. major subcellular antigens and sandfly gut antigens.

Mbati PA, Anjili CO, Odongo S, Ogaja P, Tonui W. Mbati PA, et al. Onderstepoort J Vet Res. 2000 Mar;67(1):57-63. Onderstepoort J Vet Res. 2000. PMID: 10843323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters